3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Oxaliplatin
5
Nivolumab
5
Fluorouracil
5
Taxes
4
Paclitaxel
4
Leucovorin
4
Capecitabine
4
Trastuzumab
3
zimberelimab
2
zanidatamab
2
Specimen Handling
2
Ramucirumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
zolbetuximab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tislelizumab
1
quemliclustat
1
futibatinib
1
cixutumumab
1
Radiotherapy
1
Radiation
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Cisplatin
1
Carboplatin
1
CT-P6
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.